X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1875) 1875
Magazine Article (8) 8
Conference Proceeding (5) 5
Dissertation (2) 2
Book / eBook (1) 1
Book Review (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1476) 1476
female (834) 834
amoxicillin - therapeutic use (798) 798
male (774) 774
clavulanic acids - therapeutic use (735) 735
clavulanic acid (733) 733
anti-bacterial agents - therapeutic use (623) 623
adult (540) 540
drug therapy, combination - therapeutic use (487) 487
index medicus (450) 450
middle aged (442) 442
amoxicillin-potassium clavulanate combination (399) 399
pharmacology & pharmacy (374) 374
aged (360) 360
antibiotics (341) 341
amoxicillin (328) 328
infectious diseases (300) 300
microbiology (298) 298
clavulanic acid - therapeutic use (271) 271
adolescent (269) 269
child (261) 261
bacterial infections - drug therapy (241) 241
amoxicillin - administration & dosage (231) 231
treatment outcome (231) 231
microbial sensitivity tests (228) 228
clavulanic acids - administration & dosage (224) 224
child, preschool (213) 213
animals (207) 207
ticarcillin - therapeutic use (192) 192
drug therapy, combination (187) 187
anti-bacterial agents - administration & dosage (184) 184
penicillins - therapeutic use (183) 183
acute disease (176) 176
anti-bacterial agents - pharmacology (170) 170
beta-lactamase inhibitors (170) 170
infant (170) 170
clavulanic acids - adverse effects (152) 152
prospective studies (149) 149
infections (144) 144
amoxicillin - adverse effects (143) 143
drug combinations (132) 132
drug combinations - therapeutic use (132) 132
administration, oral (119) 119
clinical trials as topic (118) 118
medicine, general & internal (116) 116
cephalosporins - therapeutic use (113) 113
clavulanic acids - pharmacology (113) 113
aged, 80 and over (111) 111
bacteria (111) 111
amoxicillin-clavulanic acid (106) 106
respiratory tract infections - drug therapy (106) 106
double-blind method (104) 104
children (103) 103
surgery (103) 103
urinary tract infections - drug therapy (103) 103
research article (101) 101
therapy (101) 101
drug therapy, combination - administration & dosage (99) 99
pharmacokinetics (99) 99
immunology (96) 96
pediatrics (96) 96
antimicrobial agents (95) 95
drug therapy, combination - adverse effects (90) 90
resistance (90) 90
amoxicillin - pharmacology (88) 88
drug resistance (88) 88
anti-bacterial agents - adverse effects (87) 87
otitis media - drug therapy (87) 87
clavulanic acid - administration & dosage (85) 85
penicillin (85) 85
risk factors (83) 83
clavulanic acid - pharmacology (82) 82
health aspects (81) 81
time factors (81) 81
drug administration schedule (79) 79
amoxicillin-potassium clavulanate combination - therapeutic use (78) 78
ampicillin (77) 77
bacteria - drug effects (77) 77
penicillin resistance (77) 77
escherichia-coli (75) 75
ticarcillin - administration & dosage (69) 69
drug resistance, microbial (68) 68
internal medicine (68) 68
management (66) 66
recurrence (66) 66
retrospective studies (66) 66
surgical wound infection - prevention & control (66) 66
diagnosis (65) 65
analysis (64) 64
drug evaluation (64) 64
drug therapy (64) 64
cephalosporins (63) 63
randomized controlled trials as topic (63) 63
beta-lactamases - metabolism (62) 62
ciprofloxacin (62) 62
pneumonia (62) 62
antimicrobial resistance (61) 61
oncology (61) 61
patients (61) 61
antibiotic prophylaxis (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1658) 1658
French (105) 105
Spanish (34) 34
German (33) 33
Japanese (28) 28
Italian (16) 16
Russian (14) 14
Polish (5) 5
Czech (4) 4
Dutch (3) 3
Hebrew (2) 2
Hungarian (2) 2
Portuguese (2) 2
Turkish (2) 2
Afrikaans (1) 1
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD009764
Background There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in chronic obstructive pulmonary disease (COPD... 
Fluoroquinolones | Quinolines | Clarithromycin | Lungs & airways | Drug Administration Schedule | Pulmonary Disease, Chronic Obstructive | Azithromycin | Antibiotic Prophylaxis | Roxithromycin | Erythromycin | Moxifloxacin | Disease Progression | Randomized Controlled Trials as Topic | Trimethoprim, Sulfamethoxazole Drug Combination | Chronic obstructive pulmonary disease (stable) | Amoxicillin | Anti‐Bacterial Agents | Aza Compounds | Clavulanic Acid | Quality of Life | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Medicine General & Introductory Medical Sciences | Other medications | Azithromycin [therapeutic use] | STABLE COPD | Humans | AIRWAY INFLAMMATION | Quinolines [therapeutic use] | Anti-Bacterial Agents [therapeutic use] | MEDICINE, GENERAL & INTERNAL | DAILY PENICILLIN | Aza Compounds [therapeutic use] | TETRACYCLINE | Erythromycin [therapeutic use] | CHRONIC-BRONCHITIS | LONG-TERM AZITHROMYCIN | Antibiotic Prophylaxis [methods] | Pulmonary Disease, Chronic Obstructive [drug therapy] | ACUTE EXACERBATIONS | INDUCED SPUTUM | Clarithromycin [therapeutic use] | DOUBLE-BLIND | Aged | HEALTH-STATUS | Aza Compounds - therapeutic use | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - adverse effects | Roxithromycin - adverse effects | Roxithromycin - therapeutic use | Antibiotic Prophylaxis - methods | Clarithromycin - therapeutic use | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Erythromycin - therapeutic use | Clavulanic Acid - adverse effects | Clavulanic Acid - therapeutic use | Azithromycin - adverse effects | Moxifloxacin - therapeutic use | Azithromycin - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - adverse effects | Quinolines - therapeutic use | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
European Respiratory Journal, ISSN 0903-1936, 11/2015, Volume 46, Issue 5, pp. 1461 - 1470
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2012, Volume 2015, Issue 6, p. CD003261
Background Impetigo is a common, superficial bacterial skin infection, which is most frequently encountered in children. There is no generally agreed standard... 
Administration, Oral | 2. Medical treatments | Mupirocin | topical antibiotics | Erythromycin | Randomized Controlled Trials as Topic | topical antiseptics | A. INFECTIOUS DISEASES AFFECTING THE SKIN | Infectious disease | Skin infections | Penicillins | Anti‐Bacterial Agents | Impetigo | Child health | systemic antibiotics | Fusidic Acid | A20 Skin diseases caused by bacteria: e.g. impetigo, boils, folliculitis, cellulitis (Liaison with Cochrane Wounds Group for bacterial wound infections) | Medicine General & Introductory Medical Sciences | Administration, Topical | SOFT-TISSUE INFECTIONS | AMOXICILLIN-CLAVULANIC ACID | B SULFATE CREAM | Humans | TOPICAL RETAPAMULIN OINTMENT | Impetigo [drug therapy] | RANDOMIZED CONTROLLED-TRIAL | RESISTANT STAPHYLOCOCCUS-AUREUS | Anti-Bacterial Agents [therapeutic use] | MEDICINE, GENERAL & INTERNAL | SKIN-STRUCTURE INFECTIONS | DOUBLE-BLIND | FUSIDIC ACID CREAM | PLACEBO-CONTROLLED TRIAL | Penicillins - therapeutic use | Fusidic Acid - administration & dosage | Mupirocin - administration & dosage | Mupirocin - therapeutic use | Penicillins - administration & dosage | Erythromycin - therapeutic use | Erythromycin - administration & dosage | Fusidic Acid - therapeutic use | Anti-Bacterial Agents - therapeutic use | Impetigo - drug therapy | Anti-Bacterial Agents - administration & dosage
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 07/2012, Volume 40, Issue 1, pp. 17 - 27
Journal Article